BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7217385)

  • 1. Pyoderma gangrenosum treated with clofazimine. Report of three cases.
    Kark EC; Davis BR; Pomeranz JR
    J Am Acad Dermatol; 1981 Feb; 4(2):152-9. PubMed ID: 7217385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyoderma gangrenosum treated with clofazimine: clinical evaluation of 7 cases.
    Rasmussen I
    Acta Derm Venereol; 1983; 63(6):552-3. PubMed ID: 6198851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clofazimine in dermatitis ulcerosa (pyoderma gangrenosum). Open clinical trial.
    Mensing H
    Dermatologica; 1988; 177(4):232-6. PubMed ID: 3066646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pyoderma gangrenosum: 2 cases with perineal localization].
    Cola B; Porzio F; Farella S
    Ann Ital Chir; 1980; 52(4):465-75. PubMed ID: 7224433
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyoderma gangrenosum associated with regional enteritis. Improvement in defective granulocyte function and healing of skin lesions during administration of clofazimine.
    Brandt L; Gärtner I; Nilsson PG; Olofsson T
    Acta Med Scand; 1977 Jan; 201(1-2):141-4. PubMed ID: 835365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pyoderma gangrenosum: Clofazimine therapy].
    Beurey J; Weber M; Delrous JL; Chaulieu Y
    Ann Dermatol Venereol; 1977 Oct; 104(10):631-4. PubMed ID: 610518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperimmunoglobulin E and impaired neutrophil functions in a case of pyoderma gangrenosum: effect of clofazimine.
    Berbis P; Mege JL; Capo C; Kaplanski S; Bongrand P; Privat Y
    J Am Acad Dermatol; 1988 Mar; 18(3):574-6. PubMed ID: 3351016
    [No Abstract]   [Full Text] [Related]  

  • 8. Clofazimine in the treatment of pyoderma gangrenosum.
    Thomsen K; Rothenborg HW
    Arch Dermatol; 1979 Jul; 115(7):851-2. PubMed ID: 453894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clofazimine. A new agent for the treatment of pyoderma gangrenosum.
    Michaëlsson G; Molin L; Ohmann S; Gip L; Lindström B; Skogh M; Trolin I
    Arch Dermatol; 1976 Mar; 112(3):344-9. PubMed ID: 1259447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenic infarction and tissue accumulation of crystals associated with the use of clofazimine (Lamprene; B663) in the treatment of pyoderma gangrenosum.
    McDougall AC; Horsfall WR; Hede JE; Chaplin AJ
    Br J Dermatol; 1980 Feb; 102(2):227-30. PubMed ID: 7387877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of lamprène in dermatology].
    Chavaz P; Laugier P
    LARC Med; 1982 Jan; 2(1):56-7. PubMed ID: 7162254
    [No Abstract]   [Full Text] [Related]  

  • 12. Pyoderma gangrenosum: successful treatment with intralesional steroids.
    Jennings JL
    J Am Acad Dermatol; 1983 Oct; 9(4):575-80. PubMed ID: 6630619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pyoderma gangrenosum with cyclosporin A.
    Soria C; Allegue F; Martin M; Ledo A
    Clin Exp Dermatol; 1991 Sep; 16(5):392-4. PubMed ID: 1794195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pyoderma gangrenosum with clofazimine. A case report and review of associated diseases.
    Lovett GW; Field JP; King LE
    J Tenn Med Assoc; 1981 Aug; 74(8):567-8. PubMed ID: 7265955
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pyoderma gangrenosum treated with prednisolone and clofazimine].
    Ohela K
    Duodecim; 1981; 97(19):1633-5. PubMed ID: 7343289
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pyoderma gangrenosum: 2 cases treated with lamprene. Immunologic study].
    De Maubeuge J; Ledoux M; Duchateau J; Schell E; Achten G
    LARC Med; 1982 Mar; 2(3):244-7. PubMed ID: 6984873
    [No Abstract]   [Full Text] [Related]  

  • 17. Superficial granulomatous pyoderma: an idiopathic granulomatous cutaneous ulceration.
    Thami GP; Kaur S; Punia RS; Kanwart AJ
    J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):159-61. PubMed ID: 12046823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lamprène. New therapeutic indications (excluding leprosy)].
    Beurey J; Weber M; Chaulieu Y
    LARC Med; 1982 Jan; 2(1):48-50, 53, 55. PubMed ID: 6219260
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of pyoderma gangrenosum with clofazimine.
    Kaplan B; Trau H; Sofer E; Feinstein A; Schewach-Millet M
    Int J Dermatol; 1992 Aug; 31(8):591-3. PubMed ID: 1428455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clofazimine treatment of pyoderma gangrenosum.
    Kark EC; Davis BR
    J Am Acad Dermatol; 1981 Sep; 5(3):346-8. PubMed ID: 7263980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.